Flavopereirine Suppresses the Progression of Human Oral Cancer by Inhibiting the JAK-STAT Signaling Pathway via Targeting LASP1Jun-wu Xu(Fujian Provincial Hospital), Jian Huang(University of Electronic Science and Technology of China)Drug Design Development and TherapyApril 1, 202110.2147/dddt.s284213Cited by 19SaveCiteExport RISWatch citationsRelated PapersSerum metabolomic profiling for predicting therapeutic response and toxicity in breast cancer neoadjuvant chemotherapy: a retrospective longitudinal study|Breast Cancer Research|2025|12Supplementary Fig 2 from A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models|Unknown|2023|0Supplementary Tables 4-7 from A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models|Unknown|2023|0Supplementary Table 2 from A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models|Unknown|2023|0Supplementary Table 11 from A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models|Unknown|2023|0